Antinéoplasique, protéine de fusion (anti-VEGF)

This page lists drugs marketed in Morocco belonging to the therapeutic class "Antinéoplasique, protéine de fusion (anti-VEGF)". For each entry, you'll find the brand name, composition (DCI), dosage, galenic form, manufacturer, public selling price (PPV in MAD) and reimbursement status (CNSS / CNOPS). Primary source: Direction du Médicament et de la Pharmacie (DMM), Ministry of Health.